# Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/autism-and-cbd-what-science-says-about-hemp-therapy-fitvifuye3z/ > **Published:** 2026-09-06T12:21:46-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:29-04:00 > **Clinical Summary:** Explore the current research on CBD's potential benefits and limitations in treating autism spectrum disorder symptoms. --- ✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyMental HealthCBDResearchHempPolicySafety Why This Matters This article matters for clinicians and their patients as it discusses CBD, a non-psychoactive compound from cannabis, and its potential therapeutic benefits for individuals with autism. Understanding the scientific evidence surrounding CBD could aid clinicians in exploring alternative treatment options for managing symptoms associated with autism, thereby improving patient care and quality of life. Clinical Summary In this article, the focus is on CBD, a non-psychoactive compound found in cannabis plants, distinct from THC. The research discussed explores CBD’s potential therapeutic benefits for individuals with autism spectrum disorder (ASD). While more studies are needed to confirm its efficacy and safety, preliminary findings suggest that CBD may help manage symptoms such as anxiety, sleep disturbances, and irritability in some ASD patients. Clinicians should be aware of the growing interest in CBD therapy for their ASD patients and consider discussing it as a potential treatment option, given its minimal side effects compared to traditional medications. Dr. Caplan’s Take “As a seasoned family physician specializing in cannabis medicine, I find the emerging research on CBD and autism intriguing. While the current body of evidence, primarily from human studies, suggests potential benefits, it’s crucial to emphasize that more rigorous, larger-scale trials are needed to confirm these findings and establish optimal dosage and treatment regimens.” Clinical Perspective 🔬 In the realm of healthcare, growing interest surrounds Cannabidiol (CBD), a non-psychoactive compound from cannabis plants, distinct from THC. Recent research on CBD and Autism suggests potential benefits, particularly in managing symptoms such as anxiety, sleep disturbances, and inflammation. However, it’s crucial to acknowledge the complexity of this area, with limited high-quality evidence and varying results across studies. Confounders like dosage, route of administration, and individual susceptibility can significantly impact outcomes. In clinical practice, healthcare providers should approach CBD as a potential adjunct therapy for autism, but further well-designed studies are needed to confirm its efficacy and safety in this population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Autism%20And%20Cbd%3A%20What%20Science%20Says%20About%20Hemp%20Therapy%20%5BFItVIfuYe3z%5D%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90818)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90818)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Autism%20And%20Cbd%3A%20What%20Science%20Says%20About%20Hemp%20Therapy%20%5BFItVIfuYe3z%5D%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90818)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://library.missouri.edu/code/pannellum/pannellum.htm?config=/%5C/video.unkk.top/pancbd2/FItVIfuYe3z](https://library.missouri.edu/code/pannellum/pannellum.htm?config=/%5C/video.unkk.top/pancbd2/FItVIfuYe3z) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).